KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Change in Accured Expenses (2016 - 2026)

Pacific Biosciences Of California has reported Change in Accured Expenses over the past 16 years, most recently at $1.0 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 95.35% year-over-year to $1.0 million; the TTM value through Dec 2025 reached -$1.2 million, up 74.13%, while the annual FY2025 figure was -$1.2 million, 74.13% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $1.0 million at Pacific Biosciences Of California, up from $188000.0 in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $22.1 million in Q4 2024 and troughed at -$18.1 million in Q2 2024.
  • A 5-year average of -$419947.4 and a median of $303000.0 in 2022 define the central range for Change in Accured Expenses.
  • Biggest five-year swings in Change in Accured Expenses: plummeted 550.73% in 2021 and later skyrocketed 5497.21% in 2024.
  • Year by year, Change in Accured Expenses stood at -$11.1 million in 2021, then skyrocketed by 207.87% to $11.9 million in 2022, then plummeted by 96.7% to $394000.0 in 2023, then skyrocketed by 5497.21% to $22.1 million in 2024, then plummeted by 95.35% to $1.0 million in 2025.
  • Business Quant data shows Change in Accured Expenses for PACB at $1.0 million in Q4 2025, $188000.0 in Q3 2025, and -$2.7 million in Q2 2025.